Epclusa
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61958-2201 -
Package NDC
61958-2201-1 -
Application number
NDA208341 -
SPL ID
4e28b652-df20-450d-9f6e-4cc6e355e223 -
SPL set ID
7f30631a-ee3b-4cfe-866b-964df3f0a44f -
UNII
WJ6CA3ZU8B -
UNII
KCU0C7RS7Z -
RxCUI
1799212 -
RxCUI
1799218 -
RxCUI
2288814 -
RxCUI
2288816 -
RxCUI
2584196 -
RxCUI
2584199 -
RxCUI
2584200 -
RxCUI
2584201
What the source publishes
- Labeler
- Gilead Sciences, Inc.
- Active ingredients
- Velpatasvir and Sofosbuvir
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Epclusa",
"splId": "4e28b652-df20-450d-9f6e-4cc6e355e223",
"labels": [
{
"setId": "7f30631a-ee3b-4cfe-866b-964df3f0a44f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f30631a-ee3b-4cfe-866b-964df3f0a44f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f30631a-ee3b-4cfe-866b-964df3f0a44f"
}
],
"routes": [
"ORAL"
],
"labeler": "Gilead Sciences, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2201-1)",
"package_ndc": "61958-2201-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20160628"
}
],
"productId": "61958-2201_4e28b652-df20-450d-9f6e-4cc6e355e223",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "61958-2201",
"deaSchedule": null,
"genericName": "Velpatasvir and Sofosbuvir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VELPATASVIR",
"strength": "100 mg/1"
},
{
"name": "SOFOSBUVIR",
"strength": "400 mg/1"
}
],
"applicationNumber": "NDA208341",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160628",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000191493",
"N0000191258",
"N0000191256",
"N0000190113",
"N0000185503",
"N0000190107",
"N0000190108",
"N0000190109"
],
"unii": [
"WJ6CA3ZU8B",
"KCU0C7RS7Z"
],
"rxcui": [
"1799212",
"1799218",
"2288814",
"2288816",
"2584196",
"2584199",
"2584200",
"2584201"
],
"spl_set_id": [
"7f30631a-ee3b-4cfe-866b-964df3f0a44f"
],
"pharm_class_epc": [
"Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
"Hepatitis C Virus NS5A Inhibitor [EPC]"
],
"pharm_class_moa": [
"RNA Replicase Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]"
],
"manufacturer_name": [
"Gilead Sciences, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61958-2201_4e28b652-df20-450d-9f6e-4cc6e355e223"